Bris­tol My­ers nabs ap­proval for Op­di­vo com­bo as first-line blad­der can­cer treat­ment

Bris­tol My­ers Squibb won an­oth­er ap­proval for its block­buster can­cer drug Op­di­vo, this time to treat a type of blad­der can­cer in com­bi­na­tion with chemother­a­pies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER